NGS Applications: Assessing Clonality and Diversity
This webinar will explore advances in next-generation sequencing for clonality and immune repertoire analysis. Speakers will present data for Ig, SHM, and TCR assays compared with PCR, as well as highlight how TCR diversity metrics may aid in characterization and assessment of hematologic malignancies. Practical applications, case studies, and future directions for integrating NGS into routine workflows will be discussed.
Speaker:
Rebecca Ramesh, MD
Jeremiah X. Karrs
EpiDirect®: Determine DNA methylation without prior DNA treatment
The webinar introduces the EpiDirect® technology, which enables direct and rapid analysis of DNA methylation - especially of the MGMT promoter - by qPCR without prior chemical conversion of the DNA material. By using special EpiPrimer™ oligonucleotides that bind specifically to methylated DNA, the method offers high specificity and sensitivity, reduces artifacts and shortens the analysis time to less than two hours.
Speaker:
Hanne Poulsen, M.Sc., Ph.D.
Complementary insights: Exploring the dual analysis of circulating tumour cells and circulating DNA
We are excited to invite you and your customers to our upcoming SensiScreen Webinar, where we will introduce how SensiScreen can improve diagnostics, stratification, and monitoring of cancer disease. We’ll explore:
- Liquid Biopsy Focus – How it helps detect disease activity earlier
- Clinical Impact – Reducing unnecessary steps and improving patient care
- Real-World Data – Insights from the latest PIK3CA liquid biopsy publication
- Custom & Hotspot Mutation Assays – Flexible solutions for various clinical needs
This session is designed for lab technicians, clinicians, and decision-makers looking for practical and effective molecular diagnostic solutions.
Speaker:
Karin Holmskov
Hansen
Esben Eller
Complementary insights: Exploring the dual analysis of circulating tumour cells and circulating DNA
In this webinar, Anne-Sophie Pailhes-Jimenez will present dual analysis data from samples taken from lung cancer patients and she will discuss how dual analysis of liquid biopsy analytes may hold potential to capture a more comprehensive picture of tumour heterogeneity and ultimately inform personalised cancer care.
Speaker:
Anna Babayan, PhD (Senior Marketing Manager at Illumina
Anne-Sophie PAILHES-JIMENEZ (Senior Director, Head of R&D at ANGLE
Molecular Third-Party Controls: Key Tools for Diagnostic Labs in Increasing Regulatory Landscape
Molecular diagnostics has rapidly emerged as a leading global technology for infectious disease testing. Consequently, clinicians depend on the results from these tests for accurate patient diagnosis. The field continues to expand and adapt to the growing needs of infectious disease testing, yet the critical importance of rigorous quality management practices in laboratories, including quality control, remains unchanged to ensure reliable results. With increasing laboratory regulations, providing guidelines for laboratory quality practices, implementing a quality management system can be complex. This webinar clarifies the key considerations for establishing a quality system in laboratories performing molecular diagnostic assays, with a focus on quality controls.
Speaker:
Dr. Andreas Eckelt (CEO, IVDRconsulting)
Jessica Van Allen PhD (Lead Technical Support Specialist, ZeptoMetrix)
Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments
Discover how measurable residual disease (MRD) standardized assays and software can aid in the development of treatment strategies.
OBJECTIVES:
- Learn how FLT3 and NPM1 mutations impact AML prognosis and treatment decisions
- Explore the significance of MRD assay sensitivity, ITD insertion size and micro-clones
- Understand the role of standardized RUO assays and the importance of objective RUO software
Speaker:
Dr. Tony Sanchez, BSc, MD, Technical Account Manager at Invivoscribe
Joshua Wemmer, MS,
Exploring Circulating Extracellular Vesicles in Liquid Biopsies for Neurological Disorders
this webinar you will discover how they identify crucial biomarkers using minimally invasive biofluids, drawing from their past research. Additionally, they will unveil their groundbreaking current project: the enrichment of brain-specific extracellular vesicles to unlock a deeper understanding of the changes that take place within the brain.
Speaker:
Bessie Meechoovet (Senior Research Associate in the Neurogenomics Division, Translational Genomics Research Institute)